OMGA
Morgan Stanley’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-28,572
| Closed | -$21.3K | – | 8294 |
|
2024
Q4 | $21.3K | Sell |
28,572
-15,411
| -35% | -$11.5K | ﹤0.01% | 6554 |
|
2024
Q3 | $53.7K | Sell |
43,983
-50,016
| -53% | -$61K | ﹤0.01% | 6197 |
|
2024
Q2 | $195K | Sell |
93,999
-34,564
| -27% | -$71.5K | ﹤0.01% | 5689 |
|
2024
Q1 | $469K | Sell |
128,563
-53,171
| -29% | -$194K | ﹤0.01% | 5345 |
|
2023
Q4 | $547K | Buy |
181,734
+98,432
| +118% | +$296K | ﹤0.01% | 5582 |
|
2023
Q3 | $179K | Buy |
83,302
+5,427
| +7% | +$11.7K | ﹤0.01% | 5634 |
|
2023
Q2 | $436K | Buy |
77,875
+5,746
| +8% | +$32.2K | ﹤0.01% | 5287 |
|
2023
Q1 | $435K | Buy |
72,129
+41,069
| +132% | +$248K | ﹤0.01% | 5333 |
|
2022
Q4 | $177K | Buy |
31,060
+13,118
| +73% | +$74.9K | ﹤0.01% | 5717 |
|
2022
Q3 | $98K | Sell |
17,942
-13,897
| -44% | -$75.9K | ﹤0.01% | 6085 |
|
2022
Q2 | $121K | Buy |
31,839
+14,847
| +87% | +$56.4K | ﹤0.01% | 6179 |
|
2022
Q1 | $106K | Buy |
16,992
+7,202
| +74% | +$44.9K | ﹤0.01% | 6268 |
|
2021
Q4 | $111K | Buy |
9,790
+9,394
| +2,372% | +$107K | ﹤0.01% | 6378 |
|
2021
Q3 | $7K | Buy |
+396
| New | +$7K | ﹤0.01% | 7424 |
|